{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vascular:lymphatic:lymph-007-secondary-causes",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-07T00:35:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "last_updated": "2026-01-07T00:35:00.000Z",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/lymphatic",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "critical",
    "aku_id": "LYMPH-007",
    "keywords": [
      "secondary lymphedema",
      "acquired lymphedema",
      "post-surgical lymphedema",
      "filariasis",
      "cancer-related lymphedema"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "lymphatic_disease",
    "isNativeDomain": true
  },
  "content": {
    "statement": "vascular:lymphatic:lymph-007-secondary-causes is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Lymphatic that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:lymphatic:lymph-007-secondary-causes helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:lymphatic:lymph-007-secondary-causes include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:lymphatic:lymph-007-secondary-causes."
    }
  },
  "clinical_features": {
    "etiology": {
      "cancer_treatment": {
        "lymph_node_dissection": "Axillary (breast), inguinal (melanoma, gynecologic), retroperitoneal",
        "radiation": "Direct lymphatic injury and delayed fibrosis",
        "tumor_invasion": "Direct obstruction of lymphatic channels or nodes",
        "incidence": "20-40% after axillary dissection, 30% after groin dissection"
      },
      "infection": {
        "filariasis": "Wuchereria bancrofti, Brugia species - >120 million affected worldwide",
        "cellulitis": "Recurrent episodes scar lymphatics; each episode worsens lymphedema",
        "tuberculosis": "Lymph node involvement can obstruct drainage"
      },
      "other": {
        "trauma": "Crush injuries, burns, extensive surgery",
        "CVI": "Chronic venous insufficiency with secondary lymphatic overload",
        "lipedema": "Lipedema can progress to lipo-lymphedema"
      }
    },
    "risk_factors": [
      "Extent of lymph node dissection (more nodes = higher risk)",
      "Concurrent radiation therapy to regional nodes",
      "Obesity (BMI >30 doubles risk)",
      "Post-operative wound complications or seroma",
      "Recurrent cellulitis or wound infections",
      "Taxane chemotherapy (possibly)",
      "Air travel (unproven but commonly cited)"
    ],
    "presentation": {
      "timing": "Days to decades after inciting event (median 1-3 years post-surgery)",
      "location": "Territory drained by damaged lymphatics",
      "progression": "Usually progressive without treatment",
      "complications": "Cellulitis, lymphangitis, skin changes, rarely lymphangiosarcoma"
    },
    "staging_ISL": {
      "Stage_0": "Latent - at risk but no visible edema",
      "Stage_I": "Reversible - pitting, resolves with elevation",
      "Stage_II": "Spontaneously irreversible - does not resolve with elevation, fibrosis",
      "Stage_III": "Lymphostatic elephantiasis - severe fibrosis, skin changes"
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Secondary Lymphedema"
    },
    "altLabel": [
      "Acquired lymphedema",
      "Cancer-related lymphedema",
      "Post-surgical lymphedema"
    ],
    "definition": {
      "@language": "en",
      "@value": "Lymphedema resulting from damage or obstruction of previously normal lymphatic vessels, most commonly from cancer treatment, infection, or trauma."
    },
    "notation": "LYMPH-007"
  },
  "relationships": {
    "prerequisites": [
      "vascular:lymphatic:lymph-002-anatomy",
      "vascular:lymphatic:lymph-003-physiology"
    ],
    "enables": [
      "vascular:lymphatic:lymph-009-complete-decongestive-therapy",
      "vascular:lymphatic:lva-001-lymphovenous-anastomosis"
    ],
    "skos:broader": [
      "vascular:lymphatic:lymphedema"
    ],
    "skos:related": [
      "vascular:oncology:lymph-node-dissection",
      "vascular:lymphatic:cellulitis"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). vascular:lymphatic:lymph-007-secondary-causes. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  },
  "pedagogical": {
    "target_audience": [
      "vascular surgery residents",
      "oncology surgeons",
      "breast surgeons",
      "lymphedema therapists"
    ],
    "estimated_time": "20min",
    "learning_objectives": [
      "Identify the major causes of secondary lymphedema",
      "Understand risk factors for cancer treatment-related lymphedema",
      "Apply ISL staging to lymphedema patients",
      "Recognize the global burden of filariasis-related lymphedema"
    ],
    "clinical_pearls": [
      "20-40% of patients develop lymphedema after axillary lymph node dissection",
      "Sentinel node biopsy reduces but does not eliminate risk (5-7%)",
      "Latency can be DECADES - counsel patients about lifelong risk",
      "Each cellulitis episode worsens lymphedema - prevention is critical",
      "Obesity doubles the risk - weight management is therapeutic",
      "Filariasis causes 120+ million cases globally - most common cause worldwide"
    ],
    "board_yield": "HIGH"
  },
  "medicalCode": [
    {
      "codingSystem": "SNOMED-CT",
      "codeValue": "234097001",
      "description": "Secondary lymphedema"
    },
    {
      "codingSystem": "ICD-10-CM",
      "codeValue": "I89.0",
      "description": "Lymphedema, not elsewhere classified"
    },
    {
      "codingSystem": "ICD-10-CM",
      "codeValue": "I97.2",
      "description": "Postmastectomy lymphedema syndrome"
    }
  ]
}